Category: Company News

HydroGraph will present its 20%-by-weight Fractal Graphene Paste at The Advanced Materials Show USA as it works to convert more than 30 customer evaluations into broader commercial adoption. Key Investor Takeaways Why HGRAF Stock Is in Focus HydroGraph is moving its recently launched Fractal Graphene Paste into the industry demonstration stage, with the company scheduled…

September deliveries increased 7.7% year over year to 37,408 vehicles, while NIO’s first-nine-month deliveries rose 49.2% to more than 300,000 units. Key Investor Takeaways Why NIO Stock Is in Focus NIO reported continued delivery growth in the third quarter, with 109,178 vehicles delivered during the three months through September, up 25.4% year over year. September…

Foghorn and Lilly will end further collaboration activities after FHD-909 failed to demonstrate sufficient efficacy, while Foghorn cuts its workforce by approximately 40% and extends its cash runway into the second half of 2029. Key Investor Takeaways Why FHTX Stock Is in Focus Foghorn Therapeutics is ending development of FHD-909 with Lilly after Phase 1…

Corexa Pharmacy’s preliminary September revenue increased more than 66% from July, supported by retail customer growth and the launch of Tollo Health products. Key Investor Takeaways Why MEDS Stock Is in Focus DataMeds AI reported that Corexa Pharmacy surpassed $1 million in preliminary, unaudited monthly revenue during September, up more than 66% from the level…

The smart retail rollout will begin with up to 50 locations and use edge AI infrastructure for loss prevention, safety, predictive maintenance and store monitoring. Key Investor Takeaways Why VEEA Stock Is in Focus Veea has secured an agreement with TROLLEE for a phased deployment of its VeeaONE edge computing platform across 1,000 unattended stores,…

The 10-year exclusive agreement covers seven countries and includes an initial binding device order, a Brazilian clinical pilot and a framework for locally manufactured devices and recurring electrode royalties. Key Investor Takeaways Why NXL Stock Is in Focus Nexalin Technology has converted its earlier South American commercialization plans into a definitive distribution agreement, giving Inovanexa…

The expanded collaboration moves beyond hybrid bonding into 3D IC integration, thermo-compression bonding, panel-scale packaging and photonics technologies designed to support AI system scaling. Key Investor Takeaways Why AMAT Stock Is in Focus Applied Materials is expanding its semiconductor packaging collaboration with Besi as AI infrastructure increases requirements for higher-density chip interconnects. Besi will join…

The planned Alberta campus adds a contemplated 6 MW of compute capacity alongside FingerMotion’s previously announced 99 MW development programme. Key Investor Takeaways Why FNGR Stock Is in Focus FingerMotion has moved to secure physical infrastructure for its Alberta AI strategy through a binding purchase agreement covering approximately 20.2 acres at 409 Pioneer Trail S.…

Wanderport is preparing an early beta launch of its AI-powered Issuer Works platform while pursuing debt restructuring, physical AI opportunities and potential strategic acquisitions. Key Investor Takeaways Why WDRP Stock Is in Focus Wanderport provided an update covering its AI product strategy, the approaching beta launch of Issuer Works and planned changes to its capital…

The FDA has accepted fenebrutinib for priority review across two forms of multiple sclerosis following three Phase III studies, moving Roche toward a potential expansion of its MS portfolio beyond Ocrevus. Key Investor Takeaways Why RHHBY Stock Is in Focus Genentech said the FDA has accepted its New Drug Application for fenebrutinib under priority review…